First-line tuberculosis therapy and drug-resistant Mycobacterium tuberculosis in prisons

Lancet

Volumn 353, Issue 9157, 1999, Pages 969-973

  Coninx, R ^a   Mathieu, C ^b   Debacker, M ^b   Mirzoev, F ^b   Ismaelov, A ^b   De Haller, R ^a   Meddings, D R ^a  

^a International Committee of the Red Cross   (Switzerland)

^b Intl Committee of the Red Cross   (Azerbaijan)

Author keywords

[No Author keywords available]

Indexed keywords

ETHAMBUTOL; ISONIAZID; RIFAMPICIN; STREPTOMYCIN;

ADULT; ANTIBIOTIC RESISTANCE; ARTICLE; AZERBAIJAN; DIET SUPPLEMENTATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; MYCOBACTERIUM TUBERCULOSIS; PATIENT COMPLIANCE; PRACTICE GUIDELINE; PRIORITY JOURNAL; PRISON; REGRESSION ANALYSIS; SPUTUM SMEAR; TREATMENT FAILURE; TUBERCULOSIS; TUBERCULOSIS CONTROL; WORLD HEALTH ORGANIZATION;

EID: 0033586422     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(98)08341-X     Document Type: Article

References (17)

1. Braun M.M., Truman B.I., Maguire B.et al. Increasing incidence of tuberculosis in a prison inmate population. JAMA. 261:1989;393-397.
2. Snider D.E. Jr., Hutton M.D. Tuberculosis in correctional institutions. JAMA. 261:1989;436-437.
3. Drobniewski F. Tuberculosis in prisons - forgotten plague. Lancet. 345:1995;948-949.
4. Tuberculosis trends in Central and Eastern Europe and countries of the former USSR. Weekly Epidemiol Rec. 4:1995;21-24.
5. WHO. Global tuberculosis control. Geneva: WHO, 1997: 66.
6. Coninx R., Eshaya-Chauvin B., Reyes H. Tuberculosis in prisons. Lancet. 346:1995;1238-1239.
7. WHO. WHO report on the tuberculosis epidemic, 1995: stop TB at the source. Geneva: WHO, 1995.
8. Coninx R., Pfyffer G.E., Mathieu C.et al. Drug resistant tuberculosis in prisons in Azerbaijan: case study. BMJ. 316:1998;1423-1425.
9. WHO. Treatment of tuberculosis: guidelines for national programmes. Geneva: WHO, 1997.
10. WHO. Managing tuberculosis at district level: a training course. Geneva: WHO, 1994.
11. Canetti G., Fox W., Khomenko A.et al. Advances in techniques of testing mycobacterial drug sensitivity, and the use of sensitivity tests in tuberculosis control programmes. Bull WHO. 41:1969;21-43.
12. Siddiqi S.H. Bactec TB system: product and procedure manual. 1989;Becton Dickinson, Maryland.
13. Pablos-Méndez A., Raviglione M.C., Laszlo A.et al. Global surveillance for antituberculosis-drug resistance. N Engl J Med. 338:1998;1641-1649.
14. European Centre for Epidemiological Monitoring of AIDS. HIV/AIDS surveillance in Europe: quarterly report no 52. Saint Maurice, France: ECEMAIDS, 1996: 11.
15. WHO. Tuberculosis control in refugee situations: an inter-agency field manual. Geneva: WHO, 1997.
16. WHO. Anti-tuberculosis drug resistance in the world: the WHO/IUATLD global project on anti-tuberculosis drug resistance surveillance. Geneva: WHO, 1997: 117.
17. Small P.M., Schafer R.W., Hopewell P.C.et al. Exogenous reinfection with multidrug-resistant mycobacterium tuberculosis in patients with advanced HIV infection. N Engl J Med. 328:1993;1137-1144.